Lemme Inc., co-founded by Kourtney Kardashian Barker, was accused in a new proposed class action of advertising its GLP-1 supplement as working like popular weight-loss drugs Wegovy and Mounjaro despite being made merely of citrus extracts.
The market for GLP-1 agonist medications—used to treat diabetes and obesity—has skyrocketed in the last few years, and Lemme is “hoping to cash in on the GLP-1 agonist craze and swindle Americans into buying their supplements instead,” according to the complaint filed Sunday in the US District Court for the Southern District of New York.
A spokesperson for the company called the lawsuit “frivolous” ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.